Regulatory policy, value of knowledge assets and innovation strategy : the case of the Orphan Drug Act
Year of publication: |
2008
|
---|---|
Authors: | Rzakhanov, Zaur |
Published in: |
Research policy : policy, management and economic studies of science, technology and innovation. - Amsterdam [u.a.] : Elsevier, ISSN 0048-7333, ZDB-ID 121149-3. - Vol. 37.2008, 4, p. 673-689
|
Subject: | Innovation | Technologiepolitik | Technology policy | Pharmakologie | Pharmacology | USA | United States |
-
A reexamination of the costs of medical R&D regulation
Philipson, Tomas J., (2012)
-
Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines?
D'Souza, Arielle, (2024)
-
Market incentives and pharmaceutical innovation
Yin, Wesley, (2008)
- More ...
-
Rzakhanov, Zaur, (2012)
-
Antitakeover provisions, managerial entrenchment and firm innovation
Chakraborty, Atreya, (2014)
-
Innovation, product development and market value : evidence from the biotechnology industry
Rzakhanov, Zaur, (2004)
- More ...